Work

Incidence, treatment patterns, and mortality for patients with breast cancer during the first year of the COVID-19 pandemic: a population-based study

Year: 2024

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-024-07562-w

Authors: José Pablo Leone, José Pablo Leone, Julieta Leone, Julieta Leone, Michael J. Hassett, Rachel A. Freedman, Jorge Avila, Carlos T. Vallejo, Nabihah Tayob, Sara M. Tolaney, Nancy U. Lin

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, St. Elizabeth's Medical Center

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Seagen, Eisai, Genentech, National Cancer Institute, Daiichi Sankyo Europe

Award: Predicting Endocrine Therapy Response In Male Breast Tumors

OpenAlex ID: W4404931607

FWCI: 0.458

Cites: 30

Cited by: 3

Related to: 10